The hospitals that feature a movie theater for patients
Mariah Taylor / beckershospitalreview - In Britain, nine hospitals have a movie theater inside their facilities for patients to watch the latest blockbusters, The New York Times reported July 8. The theaters are created and operated by nonprofit MediCinema. The cinema has 40 seats, including sp…
AI Summary: Several hospitals have installed on‑site movie theaters and screening spaces to improve patient experience, reduce isolation and offer a pleasant distraction during long stays. Administrators pitch these cinemas as low‑tech, high‑mood medicine; skeptics raise budgetary eyebrows. For patients, though, a dimmed lights screening beats another fluorescent corridor any day.
A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer
Frank Vinluan / medcitynews - Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload called an NMT inhibitor. Novartis says Myricx’s drugs could have advantages over currently available ADCs as well as those still in clinical development. The post A…
AI Summary: Novartis has struck a roughly $1 billion deal to acquire Myricx Bio, a preclinical bet aimed at securing a novel antibody‑drug conjugate payload. The move is a clear attempt to stand out in a crowded oncology market by buying potential innovation rather than inventing it in‑house — or, as finance folks call it, buying optionality.
IKS Health completes $557M TruBridge acquisition
Andrew Cass / beckershospitalreview - IKS Health has completed its $557 million acquisition of TruBridge, which provides revenue cycle management and EHR services for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health, according…
AI Summary: IKS Health has closed a $557 million deal to acquire TruBridge, integrating the acquired firm’s revenue-cycle and IT capabilities into IKS’s technology stack. The purchase accelerates IKS’s push to expand managed services for health systems, promising greater scale and product consolidation—because nothing says progress like buying your way into the future.
Tampa General sues Eli Lilly over pulled 340B discounts
Ella Jeffries / beckershospitalreview - Tampa General (Fla.) Hospital has sued Eli Lilly and Lilly USA, alleging the drugmaker’s decision to cut off the hospital’s 340B pricing access violates Florida’s Deceptive and Unfair Trade Practices Act. According to the July 2 complaint, filed in the U.…
AI Summary: Tampa General Hospital has filed suit against Eli Lilly after the company suspended discounts tied to the 340B drug-pricing program, alleging the move harmed hospitals that rely on those savings to fund patient care. The litigation highlights ongoing tensions over manufacturer discount policies and financial pressures on safety-net providers.
Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
fiercehealthcare - Health tech startup Pearl Health raised $110 million in a mix of debt and equity financing to build out its artificial intelligence platform for Medicare providers, including AI agents to handle administrative tasks.
AI Summary: Pearl Health secured $110 million in new funding to expand its technology and AI offerings for Medicare providers, aiming to boost value-based care infrastructure and support clinicians serving older patients. The cash infusion targets product development and market growth—because nothing scales value-based care like another round of venture capital.
Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
Susan Jaffe / kffhealthnews - Thousands of people who had a Medicare drug plan with zero-dollar premiums last year got small premium increases this year — and didn’t know it. They were dropped from their coverage for failing to pay amounts as little as $8, and most can’t get it again …
AI Summary: Investigations reveal that many Medicare beneficiaries who believed their drug coverage was free later discovered they had lost benefits, often because of plan changes or confusing enrollment processes. The situation exposed gaps in consumer communication and program oversight, prompting calls for clearer disclosures and stronger safeguards to prevent future coverage surprises.
Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
fiercehealthcare - Contract disputes will keep about 4,000 Brigham and Women's Hospital nurses off the job for five days, and another 450 home care clinicians on picket lines for a week.
AI Summary: Home‑care nurses at Mass General Brigham have walked off the job in a high‑visibility strike demanding better wages and benefits, halting services and forcing preparations across the system. Management and clinicians scramble to maintain patient care continuity as picket lines and negotiations intensify. Unions emphasize staffing and compensation as central unresolved issues.
American Cancer Society Reports Latest Global Cancer Statistics; Cancer Cases Approach 21 Million Worldwide, With Burden Projected to Surge 67% by 2050
cancer - New data reveal stark geographic inequities and call for urgent global action on prevention, early detection, and equitable treatment access
AI Summary: The American Cancer Society published updated global cancer statistics showing cases near 21 million and projecting a steep rise by midcentury, highlighting shifting incidence patterns and growing health system strain. The report calls for intensified prevention, screening and investment in equitable cancer control to blunt the projected surge.
- GLOBOCAN and ACS: New global cancer estimates and projections (6)
- Regional responses: conferences, national programs, and research (4)
- Survival gaps: breast, GI, GU cancers and immunotherapy access (5)
- WHO 2026 Global Cancer Report: Urgent calls for action (5)
- All Other Stories
GLOBOCAN and ACS: New global cancer estimates and projections
Regional responses: conferences, national programs, and research
Survival gaps: breast, GI, GU cancers and immunotherapy access
WHO 2026 Global Cancer Report: Urgent calls for action
All Other Stories
Epic names 4 leaders to step up after Sumit Rana’s exit
Naomi Diaz / beckershospitalreview - Epic named four executives who will take on expanded responsibilities following President Sumit Rana’s departure, according to a statement from Founder and CEO Judy Faulkner shared with Becker’s. Ms. Faulkner said Seth Howard, Mark Lipsky, Erv Walter and …
AI Summary: Epic’s president, Sumit Rana, is stepping away and the company has reorganized senior roles to cover the gap. The reshuffle names multiple leaders to take on expanded responsibilities as Epic navigates an executive transition while reassuring customers and investors that product development and client support will continue uninterrupted.
Ascension to Buy Tennessee Health System for Nearly $1B
Katie Adams / medcitynews - Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B ap…
AI Summary: Ascension announced plans to buy Williamson Health, an independent Tennessee health system, in a transaction valued at roughly $700M–$1B. The acquisition further consolidates hospital ownership in the region and will shift local governance and operational control to Ascension as the parties work through regulatory and integration steps.
Hospital groups, GPO push back on CMS’ 2027 outpatient rule
Ella Jeffries / beckershospitalreview - Four groups are condemning CMS’ proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center rule, which would cut what Medicare pays hospitals for 340B drugs and expand site-neutral payments into a new category of services. …
AI Summary: Major hospital groups and purchasing GPOs are pushing back on CMS’ proposed 2027 outpatient payment rule, warning that reimbursement changes could disrupt provider margins, patient access and group purchasing dynamics. CMS’ proposal would alter outpatient payment calculations; hospitals argue the revisions threaten financial viability of some outpatient services and request policy rework and deeper stakeholder engagement.
Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
fiercehealthcare - Evernorth has unveiled a new specialty pharmacy program that leans on AI to support a better experience for patients with complex conditions.
AI Summary: Evernorth announced a $100 million investment to roll out an AI‑driven specialty pharmacy program designed to streamline specialty drug management, improve medication access, and optimize operations. The program blends automation and data analytics to cut friction in high‑cost therapies — promising efficiency gains if the tech behaves, which is always the question.
Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine
Frank Vinluan / medcitynews - FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a stan…
AI Summary: Orca Bio’s off‑the‑shelf allogeneic cell therapy received FDA approval, marking a milestone for engineered living medicines. Regulators cleared the product after pivotal efficacy and manufacturing data, offering broader access to cellular therapy but spotlighting cost, supply logistics and the need for robust post‑market safety surveillance.
'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial
medicalxpress - A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers sho…
AI Summary: The POLY‑HF randomized trial found that a fixed‑dose 'polypill' for heart failure with reduced ejection fraction cut hospitalizations and emergency visits by roughly 60%, improving adherence and standardizing therapy. Results suggest a pragmatic, low‑complexity intervention could deliver substantial health‑system benefits if adopted broadly and monitored for implementation challenges.
American Hospital Association names Steve Walsh as next CEO
fiercehealthcare - Walsh is currently the head of the Massachusetts Hospital Association, and will be taking the national stage at a moment of substantial policy and political challenges for the hospital industry.
AI Summary: Steve Walsh was named the next CEO of the American Hospital Association, replacing outgoing leadership and signaling continuity with a public-sector advocacy background. The appointment centers on navigating hospital policy, membership priorities and advocacy at a time of industry consolidation and regulatory pressure — yes, more meetings and memos ahead.
ACA marketplace enrollment down by 3M as of February, new federal data show
fiercehealthcare - New federal data show that 19.2 million individuals were enrolled in Affordable Care Act marketplace plans as of February, down by nearly 3 million from 2025.
AI Summary: New federal data show ACA marketplace enrollment fell by roughly three million people as of February, signaling continuing declines in the individual market. Officials cite affordability, policy and outreach gaps as contributing factors, leaving consumers with narrower plan choices and potential cost pressure. The drop revives debate over measures to stabilize enrollment and access.
- ACA enrollment drops by about 3 million (5)
- Insurers seek median 14% ACA premium increases in 2027 (6)
- All Other Stories
ACA enrollment drops by about 3 million
Insurers seek median 14% ACA premium increases in 2027
All Other Stories
A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management
Sandeep Palakodeti / medcitynews - For seniors, the change in policy will dramatically expand access to a revolutionary medication. But there are also significant risks.The post A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management …
AI Summary: Medicare’s planned GLP‑1 coverage “bridge” has kicked off a scramble: policy analysts warn a narrow drug‑centric approach won’t fix weight management, while major retailers are rolling out programs and partnerships to plug access gaps. Expect patchwork solutions, eager pharmacies, and a chorus asking for a more holistic long‑term plan.
- Clinical risks and long-term effectiveness debate (5)
- Medicare Bridge rollout, eligibility and cost questions (5)
- Online prescribing, oversight and soaring GLP‑1 use (4)
- Retailers, pharmacies and manufacturers rush to plug access gaps (4)
- All Other Stories
Clinical risks and long-term effectiveness debate
Medicare Bridge rollout, eligibility and cost questions
Online prescribing, oversight and soaring GLP‑1 use
Retailers, pharmacies and manufacturers rush to plug access gaps
All Other Stories
FDA Approves Gilead’s Trodelvy, Alone and With Merck’s Keytruda, in First-Line Metastatic TNBC
oncodaily - Decision delivers the first ADC-based regimens for previously untreated triple-negative breast cancer across PD-L1 status, a PD-L1-positive Keytruda combination plus a monotherapy option for immunotherapy-ineligible patients. The U.S. Food and […]
AI Summary: The FDA approved sacituzumab govitecan (Trodelvy) as both monotherapy and in combination with pembrolizumab (Keytruda) for first-line treatment of metastatic triple‑negative breast cancer, expanding options for a hard-to-treat population. Regulators cited clinical benefit in appropriate patients, reshaping treatment sequencing and payer discussions.
As PBM industry shifts, LucyRx and Abarca Health merge to build scale
fiercehealthcare - Amid significant shifts in the pharmacy benefit management industry, LucyRx and Abarca Health have revealed plans to merge to build the scale necessary to compete in this changing landscape.
AI Summary: Two independent pharmacy benefit managers, LucyRx and Abarca Health, announced a combination to build scale amid industry consolidation. The deal aims to bolster negotiating leverage, broaden client reach and offer an alternative to dominant PBMs—because apparently one disruptor wasn’t enough to disrupt the disruptors.
Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
Darius Tahir / kffhealthnews - Medicare is testing the use of artificial intelligence to preapprove several healthcare services. Federal health officials say prior authorization can help reduce fraud and contain costs. But doctors and patients describe the trial as “horrendous” and ful…
AI Summary: Reports show Medicare’s push to deploy AI in administrative and clinical workflows has inadvertently created errors and delays, snaring patients and clinicians in a tangle of misclassifications, coverage denials and technical glitches. The rollout highlights risks of scaling automated decision tools without robust testing, oversight and clear escalation pathways for frontline staff.
- Fixing AI: governance, health systems and nursing oversight (4)
- Medicare AI pilot snarls care with denials and delays (3)
- When AI takes action: autonomous clinical agents create risks (4)